Midlife systemic inflammation is associated with frailty in later life: The ARIC study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 74, Issue 3, 2019, Pages 343-349

  Walker, Keenan A ^a   Walston, Jeremy ^a   Gottesman, Rebecca F ^a,b   Kucharska Newton, Anna ^c   Palta, Priya ^c   Windham, B Gwen ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c IL   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Acute phase proteins; C reactive protein; Cohort study; Immune system; Risk factor

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; FIBRINOGEN; VON WILLEBRAND FACTOR;

AGED; BLOOD; COMPLICATION; FEMALE; FRAILTY; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR;

AGED; BIOMARKERS; C-REACTIVE PROTEIN; FACTOR VIII; FEMALE; FIBRINOGEN; FRAILTY; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RISK FACTORS; VON WILLEBRAND FACTOR;

EID: 85051712887     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gly045     Document Type: Article

References (23)

1. Fried LP, Tangen CM, Walston J, et al; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156. doi:10.1093/gerona/56.3.M146
2. Klein BE, Klein R, Knudtson MD, Lee KE. Frailty, morbidity and survival. Arch Gerontol Geriatr. 2005;41:141-149. doi:10.1016/j.archger.2005.01.002
3. Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: A systematic review. J Am Geriatr Soc. 2012;60:1487-1492. doi:10.1111/j.1532-5415.2012.04054.x
4. Turusheva A, Frolova E, Korystina E, et al. Do commonly used frailty models predict mortality, loss of autonomy and mental decline in older adults in northwestern Russia? A prospective cohort study. BMC Geriatr. 2016;16:98. doi:10.1186/s12877-016-0276-4
5. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59:255-263. doi:10.1093/gerona/59.3.M255
6. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev. 2011;10:319-329. doi:10.1016/j.arr.2010.11.002
7. Baylis D, Bartlett DB, Syddall HE, et al. Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people. Age (Dordr). 2013;35:963-971. doi:10.1007/s11357-012-9396-8
8. Gale CR, Baylis D, Cooper C, Sayer AA. Inflammatory markers and incident frailty in men and women: the English longitudinal study of ageing. Age (Dordr). 2013;35:2493-2501. doi:10.1007/s11357-013-9528-9
9. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4-S9. doi:10.1093/gerona/glu057
10. Barzilay JI, Blaum C, Moore T, et al. Insulin resistance and inflammation as precursors of frailty: the cardiovascular health study. Arch Intern Med. 2007;167:635-641. doi:10.1001/archinte.167.7.635
11. Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study-I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989;61:15-19.
12. Parrinello CM, Grams ME, Couper D, et al. Recalibration of blood analytes over 25 years in the Atherosclerosis Risk in Communities Study: impact of recalibration on chronic kidney disease prevalence and incidence. Clin Chem. 2015;61:938-947. doi:10.1373/clinchem.2015.238873
13. Kucharska-Newton AM, Palta P, Burgard S, et al. Operationalizing frailty in the atherosclerosis risk in communities study cohort. Journals Gerontol Ser A Biol Sci Med Sci. 2016;72:382-388. doi:10.1093/gerona/glw144
14. Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and non-traditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16:529-538. doi:10.1681/ASN.2004080656
15. Biasucci LM; CDC; AHA. CDC/AHA workshop on markers of inflammation and cardiovascular disease: Application to clinical and public health practice: Clinical use of inflammatory markers in patients with cardiovascular diseases: A background paper. Circulation. 2004;110:e560-e567. doi:10.1161/01.CIR.0000148983.88334.80
16. Puts MT, Visser M, Twisk JW, Deeg DJ, Lips P. Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol (Oxf). 2005;63:403-411. doi:10.1111/j.1365-2265.2005.02355.x
17. Soysal P, Stubbs B, Lucato P, et al. Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev. 2016;31:1-8. doi:10.1016/j.arr.2016.08.006
18. Xu M, Tchkonia T, Ding H, et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc Natl Acad Sci USA. 2015;112:E6301-E6310. doi:10.1073/pnas.1515386112
19. Mekli K, Nazroo JY, Marshall AD, Kumari M, Pendleton N. Proinflammatory genotype is associated with the frailty phenotype in the English Longitudinal Study of Ageing. Aging Clin Exp Res. 2016;28:413-421. doi:10.1007/s40520-015-0419-z
20. Weng W, Liang Y, Kimball ES, et al. Decreasing incidence of type 2 diabetes mellitus in the United States, 2007-2012: Epidemiologic findings from a large US claims database. Diabetes Res Clin Pract. 2016;117:111-118. doi:10.1016/j.diabres.2016.04.043
21. Hirsch C, Anderson ML, Newman A, et al; Cardiovascular Health Study Research Group. The association of race with frailty: the cardiovascular health study. Ann Epidemiol. 2006;16:545-553. doi:10.1016/j.annepidem.2005.10.003
22. Kim CX, Bailey KR, Klee GG, et al. Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study. Morty RE, ed. PLoS One. 2010;5:e9065. doi:10.1371/journal.pone.0009065
23. Trombetti A, Hars M, Hsu F-C, et al. Effect of physical activity on frailty: secondary analysis of a randomized controlled trial. Ann Intern Med. 2018;168:309-316. doi:10.7326/M16-2011